Cisplatin| Versus Carboplatin|Based Chemotherapy in First|Line ...

Cisplatin- versus carboplatin-based chemotherapy in first ... - PubMed

Our individual patient data meta-analysis suggests that cisplatin-based chemotherapy is slightly superior to carboplatin-based chemotherapy ...

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line ...

Our meta-analysis of individual patient data suggests no differences in efficacy between cisplatin and carboplatin in the first-line treatment of SCLC.

Cisplatin- versus carboplatin-based chemotherapy in first-line ...

This individual patient data meta-analysis showed that cisplatin should remain the platinum agent in chemotherapy for non-small cell lung cancer, ...

Efficacy and safety of first-line carboplatin-versus cisplatin-based ...

Differences in drug-related toxicities were observed between carboplatin- and cisplatin-based chemotherapy for thrombocytopenia, anaemia, neurotoxicity, and the ...

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line ...

Our individual patient data meta-analysis suggests that cisplatin-based chemotherapy is slightly superior to carboplatin-based chemotherapy in ...

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line ...

Cisplatin- Versus Carboplatin-Based Chemotherapy ... Randomized trials comparing carboplatin to cisplatin in first-line treatment of advanced NSCLC were iden-.

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer ...

The backbone of chemotherapy regimens in both is a platinum-etoposide doublet: cisplatin is traditionally the preferred platinum agent in the ...

Long-Standing Debate on Cisplatin- Versus Carboplatin-Based ...

However, the results of these trials are conflicting; cisplatin-based chemotherapy was superior to carboplatin-based chemotherapy in terms of survival in ...

Cisplatin and carboplatin-based chemotherapy in the first-line ...

Patients treated with carboplatin were older than patients receiving cisplatin (mean age 67 versus 61 years; p < 0.001), had poorer performance status (p < ...

Comparative effectiveness of cisplatin-based and carboplatin-based ...

Cisplatin-based, as compared with carboplatin-based, chemotherapy significantly increases the likelihood of both OR and CR in patients with metastatic UC.

Cisplatin or carboplatin for advanced non-small cell lung cancer

In the first-line setting, targeted therapy has replaced cytotoxic chemotherapy ... Efficacy and safety of first-line carboplatin-versus cisplatin-based ...

Carboplatin- or cisplatin-based chemotherapy in first-line treatment ...

37). There was no evidence of treatment difference between the cisplatin and carboplatin arms according to sex, stage, performance status, or age. Median PFS ...

Determine cisplatin or carboplatin in first-line chemotherapy for ...

Elderly mUC patients treated with cisplatin-based chemotherapy had a survival benefit and better safety profiles than carboplatin.

A meta-analysis comparing cisplatin-based to carboplatin-based ...

Three studies [11, 14, 20] were limited to SCCHN excluding NPC. Cisplatin-based chemotherapy was also associated with a non-significant lower ...

First-Line Chemotherapy Treatment of Advanced Non–Small

Overall, the authors report that the use of cisplatin-based doublets was not associated with a better survival than that of carboplatin-based ones. (8.1 versus ...

Effectiveness of adjuvant carboplatin-based chemotherapy ...

Cisplatin and vinorelbine given intravenously is a well-established adjuvant chemotherapy regimen after surgery for early non-small cell lung cancer.

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the ...

Patients in the paclitaxel–carboplatin group had a higher risk of a prolonged time to finish 6 cycles of the front-line chemotherapy after PCS than those in ...

or Cisplatin-Based Chemotherapy in First-Line Treatment of Small ...

PDF | Since treatment efficacy of cisplatin- or carboplatin-based chemotherapy in the first-line treatment of small-cell lung cancer (SCLC) ...

Cisplatin Versus Carboplatin in NSCLC: Is There One “Best” Answer?

Meta-analyses of palliative chemotherapy indicate consistent survival advantages with cisplatin-based therapy over carboplatin; however, the ...

Carboplatin versus cisplatin in combination with etoposide in the first ...

Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with poor survival, and platinum-etoposide chemotherapy is ...